STERIS (NYSE:STE) Given “Overweight” Rating at Stephens
STERIS (NYSE:STE – Get Free Report)‘s stock had its “overweight” rating reissued by Stephens in a research note issued to investors on Thursday,Benzinga reports. They presently have a $250.00 price target on the medical equipment provider’s stock. Stephens’ price objective would suggest a potential downside of 0.84% from the company’s previous close. A number of […]
STERIS (NYSE:STE – Get Free Report)‘s stock had its “overweight” rating reissued by Stephens in a research note issued to investors on Thursday,Benzinga reports. They presently have a $250.00 price target on the medical equipment provider’s stock. Stephens’ price objective would suggest a potential downside of 0.84% from the company’s previous close. A number of […]
